Skip to main content
SpringerLink
Log in

Allergies in COVID-19 and Post-COVID Syndrome

  • Chapter
  • First Online:
Textbook of Allergen Tolerance

Abstract

This chapter focuses on the immunity and atopic allergies in COVID and post-COVID syndrome. The pandemic SARS-CoV-2 infection has added to our knowledge about immune reactions and responses, uncommon clinical situations, risk factors for poor outcomes, and promoted novel treatment approaches. We consider the process of viral entry in a host cell and how Th2-cytokines can inhibit it, and corticosteroids suppress SARS-CoV-2 replication. There are controversial data concerning atopic allergies, mainly asthma, during COVID-19, and multifactorial influence on disease outcomes and residual changes. Systematic reviews, meta-analyses, and online surveys allow us a vision of the whole panorama.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Khan MMA, Khan MN, Mustagir MG, Rana J, Islam MS, Kabir MI. Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: a systematic review and meta-analysis. J Glob Health. 2020;10(2):020503. https://doi.org/10.7189/jogh.10.020503.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–80.e8. https://doi.org/10.1016/j.cell.2020.02.052.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ledford H. Coronavirus reinfections: three questions scientists are asking. Nature. 2020;585:168–9. https://doi.org/10.1038/d41586-020-02506-y.

    Article  CAS  PubMed  Google Scholar 

  4. Wauters E, Thevissen K, Wauters C, Bosisio FM, De Smet F, Gunst J, et al. Establishing a unified COVID-19 “Immunome”: integrating coronavirus pathogenesis and host immunopathology. Front Immunol. 2020;11:1642. https://doi.org/10.3389/fimmu.2020.01642.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. https://doi.org/10.1016/S0140-6736(20)30628-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Niles MA, Gogesch P, Kronhart S, Iannazzo SO, Kochs G, Waibler Z, Anzaghe M. Macrophages and dendritic cells are not the major source of pro-inflammatory cytokines upon SARS-CoV-2 infection. Front Immunol. 2021;12:647824. https://doi.org/10.3389/fimmu.2021.647824.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Larenas-Linnemann DE, Ortega-Martell JA, Brandón-Vijil MV, Rodríguez-Pérez N, Luna-Pech JA, Estrada-Cardona A, et al. Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: possible favorable mechanisms of interaction. Allergy Asthma Proc. 2021;42(3):187–97. https://doi.org/10.2500/aap.2021.42.210013.

    Article  CAS  PubMed  Google Scholar 

  8. Lindsley AW, Schwartz JT, Rothenberg ME. Eosinophil responses during COVID-19 infections and coronavirus vaccination. J Allergy Clin Immunol. 2020;146:1–7. https://doi.org/10.1016/j.jaci.2020.04.021.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rowlands M, Segal F, Hartl D. Myeloid-derived suppressor cells as a potential biomarker and therapeutic target in COVID-19. Front Immunol. 2021;12:697405. https://doi.org/10.3389/fimmu.2021.697405.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Islam H, Chamberlain TC, Mui AL, Little JP. Elevated interleukin-10 levels in COVID-19: potentiation of pro-inflammatory responses or impaired anti-inflammatory action? Front Immunol. 2021;12:677008. https://doi.org/10.3389/fimmu.2021.677008.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Shi J, Zhou J, Zhang X, Hu W, Zhao J-F, Wang S, et al. Single-cell transcriptomic profiling of MAIT cells in patients with COVID-19. Front Immunol. 2021;12:700152. https://doi.org/10.3389/fimmu.2021.700152.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. Overview of immune response during SARS-CoV-2 infection: lessons from the past. Front Immunol. 2020;11:1949. https://doi.org/10.3389/fimmu.2020.01949.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Vabret N, Britton GJ, Gruber C, Hegde A, Kim J, Kuksin M, et al. Immunology of COVID-19: current state of the science. Immunity. 2020;52:910–41. https://doi.org/10.1016/j.immuni.2020.05.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Okba NMA, Müller MA, Li W, Wang C, Geurtsvan Kessel CH, Corman VM, et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients. Emerg Infect Dis. 2020;26(7):1478–88. https://doi.org/10.3201/eid2607.200841.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Brynjolfsson SF, Sigurgrimsdottir H, Einarsdottir ED, Bjornsdottir GA, Armannsdottir B, Baldvinsdottir GE, et al. Detailed multiplex analysis of SARS-CoV-2 specific antibodies in COVID-19 disease. Front Immunol. 2021;12:695230. https://doi.org/10.3389/fimmu.2021.695230.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Corey L, Beyrer C, Cohen MS, Michael NL, Bedford T, Rolland M. SARS-CoV-2 variants in patients with immunosuppression. N Engl J Med. 2021;385(6):562–6. https://doi.org/10.1056/NEJMsb2104756.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Copley HC, Gragert L, Leach AR, Kosmoliaptsis V. Influence of HLA class II polymorphism on predicted cellular immunity against SARS-CoV-2 at the population and individual level. Front Immunol. 2021;12:669357. https://doi.org/10.3389/fimmu.2021.669357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Guihot A, Litvinova E, Autran B, Debre P, Vieillard V. Cell-mediated immune responses to COVID-19 infection. Front Immunol. 2020;11:1662. https://doi.org/10.3389/fimmu.2020.01662.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Centers for Disease Control and Prevention. People with certain medical conditions. 15 March 2021. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html

  20. Timberlake DT, Narayanan D, Ogbogu PU, et al. Severity of COVID-19 in hospitalized patients with and without atopic disease. World Allergy Organ J. 2021;14(2):100508. https://doi.org/10.1016/j.waojou.2021.100508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Joshi A, Mullakary R, Iyer VN. Successful treatment of coronavirus disease 2019 in a patient with asthma. Allergy Asthma Proc. 2020;41(4):296–300. https://doi.org/10.2500/aap.2020.41.200044.

    Article  CAS  PubMed  Google Scholar 

  22. Jackson DJ, Busse WW, Bacharier LB, Kattan M, O'Connor GT, Wood RA, et al. Association of respiratory allergy, asthma and expression of the SARS-CoV-2 receptor, ACE-2. J Allergy Clin Immunol. 2020;146(1):203–6.e3. https://doi.org/10.1016/j.jaci.2020.04.009.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Bradding P, Richardson M, Hinks TSC, Howarth PH, Choy DF, Arron JR, et al. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19. J Allergy Clin Immunol. 2020;146(1):208–11. https://doi.org/10.1016/j.jaci.2020.05.013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Kimura H, Francisco D, Conway M, Martinez FD, Vercelli D, Polverino F, et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020;146(1):80–8.e8. https://doi.org/10.1016/j.jaci.2020.05.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Wark PAB, Pathinayake PS, Kaiko G, Nichol K, Ali A, Chen L, Sutanto EN, Garratt LW, Sohal SS, Lu W, Eapen MS, Oldmeadow C, Bartlett N, Reid A, Veerati P, Hsu AC, Looi K, Iosifidis T, Stick SM, Hansbro PM, Kicic A. ACE2 expression is elevated in airway epithelial cells from older and male healthy individuals but reduced in asthma. Respirology. 2021;26(5):442–51. https://doi.org/10.1111/resp.14003.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Kermani NZ, Song WJ, Badi Y, Versi A, Guo Y, Sun K, Bhavsar P, Howarth P, Dahlen SE, Sterk PJ, Djukanovic R, Adcock IM, Chung KF; U-BIOPRED Consortium. Sputum ACE2, TMPRSS2 and FURIN gene expression in severe neutrophilic asthma. Respir Res. 2021;22:10. https://doi.org/10.1186/s12931-020-01605-8.

    Article  CAS  Google Scholar 

  27. Tanno LK, Demoly P, Martin B, Berstein J, Morais-Almeida M, Levin M, et al. Allergy and coronavirus disease (COVID-19) international survey: real-life data from the allergy community during the pandemic. World Allergy Organ J. 2021;14(2):100515. https://doi.org/10.1016/j.waojou.2021.100515.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Ramakrishnan RK, Al Heialy S, Hamid Q. Implications of preexisting asthma on COVID-19 pathogenesis. Am J Physiol Lung Cell Mol Physiol. 2021;320(5):L880–91. https://doi.org/10.1152/ajplung.00547.2020.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Skevaki C, Karsonova A, Karaulov A, Xie M, Renz H. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol. 2020;146:1295–301. https://doi.org/10.1016/j.jaci.2020.09.017.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Sitek AN, Ade JM, Chiarella SE, Divekar RD, Pitlick MM, Iyer VN, et al. Outcomes among patients with COVID-19 and asthma: a systematic review and meta-analysis. Allergy Asthma Proc. 2021;42:267–73. https://doi.org/10.2500/aap.2021.42.210041.

    Article  CAS  PubMed  Google Scholar 

  31. Mahdavinia M, Foster KJ, Jaurequi E, Moore D, Adnan D, Andy-Nweye AB, et al. Asthma prolongs incubation in COVID-19. J Allergy Clin Immunol Pract. 2020;8(7):2388–91. https://doi.org/10.1016/j.jaip.2020.05.006.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Guterres DS, Dos Santos AC, Laubi MAPM, Brandão V, Saito T, Lima G. COVID-19 pandemia: atopy and prospective analysis of the clinical evolution of patients infected with the SARS-CoV-2 virus. J Allergy Clin Immunol. 2021;147(2 Suppl):AB79. https://doi.org/10.1016/j.jaci.2020.12.303.

    Article  CAS  PubMed Central  Google Scholar 

  33. Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53:368–70. https://doi.org/10.1016/j.jmii.2020.03.005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA Jr, Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020;146:327–9. https://doi.org/10.1016/j.jaci.2020.06.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ferastraoaru D, Hudes G, Jerschow E, Jariwala S, Karagic M, de Vos G, et al. Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 2021;9(3):1152–62. https://doi.org/10.1016/j.jaip.2020.12.045.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Lavoignet CE, Le Borgne P, Chabrier S, Bidoire J, Slimani H, Chevrolet-Lavoignet J, et al. White blood cell count and eosinopenia as valuable tools for the diagnosis of bacterial infections in the ED. Eur J Clin Microbiol Infect Dis. 2019;38:1523–32. https://doi.org/10.1007/s10096-019-03583-2.

    Article  CAS  PubMed  Google Scholar 

  37. Li X, Yin D, Yang Y, Bi C, Wang Z, Ma G, et al. Eosinophil: a nonnegligible predictor in COVID-19 re-positive patients. Front Immunol. 2021;12:690653. https://doi.org/10.3389/fimmu.2021.690653.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Butler MW, O'Reilly A, Dunican EM, Mallon P, Feeney ER, Keane MP, McCarthy C. Prevalence of comorbid asthma in COVID-19 patients. J Allergy Clin Immunol. 2020;146(2):334–5. https://doi.org/10.1016/j.jaci.2020.04.061.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Morais-Almeida M, Bousquiet J. COVID-19 and asthma: to have or not to have T2 inflammation makes a difference? Pulmonology. 2020;26(5):261–3. https://doi.org/10.1016/j.pulmoe.2020.05.003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kurtuluş A, Yesilkaya S, Topel M, Turkyulmaz S, Ercelebi DC, Oncul A, et al. COVID-19 in a patient with severe asthma using mepolizumab. Allergy Asthma Proc. 2021;42(2):e55–7. https://doi.org/10.2500/aap.2021.42.200125.

    Article  CAS  Google Scholar 

  41. García-Moguel I, Díaz Campos R, Alonso Charterina S, Fernández Rodríguez C, Crespo JF. COVID-19, severe asthma, and biologics. Ann Allergy Asthma Immunol. 2020;125:357–9. https://doi.org/10.1016/j.anai.2020.06.012.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Izquierdo-Domínguez A, Rojas-Lechuga MJ, Alobid I. Management of allergic diseases during COVID-19 outbreak. Curr Allergy Asthma Rep. 2021;21:8. https://doi.org/10.1007/s11882-021-00989-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Guvey A. How does allergic rhinitis impact the severity of COVID-19?: a case-control study. Eur Arch Otorhinolaryngol. 2021;278(11):4367–71. https://doi.org/10.1007/s00405-021-06836-z.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Suzaki I, Kobayashi H. Coronavirus disease 2019 and nasal conditions: a review of current evidence. In Vivo. 2021;35:1409–17. https://doi.org/10.21873/invivo.12393.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Miodońska M, Bogacz A, Mróz M, Mućka S, Boźek A. The effect of SARS-CoV-2 virus infection on the course of atopic dermatitis in patients. Medicina. 2021;57:521. https://doi.org/10.3390/medicina57060521.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Carugno A, Raponi F, Locatelli AG, Vezzoli P, Gambini DM, Di Mercurio M, et al. No evidence of increased risk for coronavirus disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy. J Eur Acad Dermatol Venereol. 2020;34(9):e433–4. https://doi.org/10.1111/jdv.16552.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Nguyen C, Yale K, Casale F, Ghigi A, Zheng K, Silverberg JI, Mesinkovska NA. SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study. Br J Dermatol. 2021;185(3):640–1. https://doi.org/10.1111/bjd.20435.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Gong F, Dai Y, Zheng T, Cheng L, Zhao D, Wang H, et al. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals. J Clin Invest. 2020;130(12):6588–99. https://doi.org/10.1172/JCI141054.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. The Lancet. Understanding long COVID: a modern medical challenge. Lancet. 2021;398(10302):725. https://doi.org/10.1016/S0140-6736(21)01900-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Gattinger P, Borochova K, Dorofeeva Y, Henning R, Kiss R, Kratzer B, et al. Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus-receptor binding. Allergy. 2021;76(3):878–83. https://doi.org/10.1111/all.14523.

    Article  CAS  PubMed  Google Scholar 

  51. Klimov VV. Adaptive immune response. In: From basic to clinical immunology. Cham: Springer; 2019. https://doi.org/10.1007/978-3-030-03323-4.

    Chapter  Google Scholar 

  52. Fiocchi A, Jensen-Jarolim E. SARS-COV-2, can you be over it? World Allergy Organ J. 2021;14(2):100514. https://doi.org/10.1016/j.waojou.2021.100514.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Kared H, Redd AD, Bloch EM, Bonny TS, Sumatoh H, Kairi F, et al. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. J Clin Invest. 2021;131(5):e145476. https://doi.org/10.1172/JCI145476.

    Article  CAS  PubMed Central  Google Scholar 

  54. Redd AD, Nardin A, Kared H, Bloch EM, Pekosz A, Laeyendecker O, et al. CD8+ T cell responses in COVID-19 convalescent individuals target conserved epitopes from multiple prominent SARS-CoV-2 circulating variants. Open Forum Infect Dis. 2021;8(7):ofab143. https://doi.org/10.1093/ofid/ofab143.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Trinkmann F, Muller M, Reif A, Kahn N, Kreuter M, Trudzinski F, et al. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. Eur Respir J. 2021;57(2):2003002. https://doi.org/10.1183/13993003.03002-2020.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Beurnier A, Jutant E-M, Jevnikar M, Boucly A, Pichon J, Preda M, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J. 2020;56(5):2001875. https://doi.org/10.1183/13993003.01875-2020.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Dayal AK, Sinha V. Trend of allergic rhinitis post COVID-19 pandemic: a retrospective observational study. Indian J Otolaryngol Head Neck Surg. 2020;20:1–3. https://doi.org/10.1007/s12070-020-02223-y.

    Article  Google Scholar 

  58. Garcia-Pachon E, Grau-Delgado J, Soler-Sempere MJ, Zamora-Molina L, Baeza-Martinez C, Ruiz-Alcaraz S, Padilla-Navas I. Low prevalence of post-COVID-19 syndrome in patients with asthma. J Infect. 2021;82(6):276–316. https://doi.org/10.1016/j.jinf.2021.03.023.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Moreno-Pérez O, Merino E, Leon-Ramirez J-M, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378–83. https://doi.org/10.1016/j.jinf.2021.01.004.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al. The inhaled steroid ciclesonide blocks SARS-CoV-2 RNA replication by targeting the viral replication-transcription complex in cultured cells. J Virol. 2020;95(1):e01648–20. https://doi.org/10.1128/JVI.01648-20.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Song W-J, Hui CKM, Hull JH, Birring SS, McGarvey L, Mazzone SB, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses. Lancet. 2021;9:533–44. https://doi.org/10.1016/S2213-2600(21)00125-9.

    Article  CAS  Google Scholar 

  62. Carlton SM. Nociceptive primary afferents: they have a mind of their own. J Physiol. 2014;592(16):3403–11. https://doi.org/10.1113/jphysiol.2013.269654.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Dror AA, Eisenbach N, Marshak T, Layous E, Zigon A, Shivatzki S, et al. Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(10):3590–3. https://doi.org/10.1016/j.jaip.2020.08.035.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Patella V, Delfino G, Florio G, Spadaro G, Bianchi FC, Senna G, Di Gioacchino M. Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era. Clin Mol Allergy. 2020;18:18. https://doi.org/10.1186/s12948-020-00134-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Milman O, Yelin I, Aharony N, Katz R, Herzel E, Ben-Tov A, et al. Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals. Nat Med. 2021;27(8):1367–9. https://doi.org/10.1038/s41591-021-01407-5.

    Article  CAS  PubMed  Google Scholar 

  66. Krause PR, Fleming TR, Longini IM, Peto R, Briand S, Heymann DL, et al. SARS-CoV-2 variants and vaccines. N Engl J Med. 2021;385:179–86. https://doi.org/10.1056/NEJMsr2105280.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Immunology and Allergy Department, Siberian State Medical University, Tomsk, Russia

    Vladimir V. Klimov

Authors
  1. Vladimir V. Klimov
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vladimir V. Klimov .

10.1 Electronic Supplementary Material

Immune Responses to SARS-CoV-2 (MP4 59364 kb)

Immune Responses to SARS-CoV-2 (MP4 66838 kb)

Audio 10.1

(MP3 15570 kb)

Audio 10.2

(MP3 8619 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Klimov, V.V. (2022). Allergies in COVID-19 and Post-COVID Syndrome. In: Textbook of Allergen Tolerance . Springer, Cham. https://doi.org/10.1007/978-3-031-04309-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-04309-3_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-04308-6

  • Online ISBN: 978-3-031-04309-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation